Trial ID or NCT#
NCT01336803
Status
Purpose
This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.
Official Title
Pilot Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Eligibility Criteria
Ages Eligible for Study: 10 Years to 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Heike Daldrup-Link
Pediatric radiologist
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Neyssa Marina
Contact us to find out if this trial is right for you.
CONTACT
Anne Muehe
(650) 724-3191
View on ClinicalTrials.gov